about
Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysisThe impact of renal impairment on long-term safety and effectiveness of drug-eluting stentsPreoperative scallop-by-scallop assessment of mitral prolapse using 2D-transthoracic echocardiography.Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents.Role of Niacin in Current Clinical Practice: A Systematic Review.Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis.Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.Drug-eluting coronary-artery stents.Management of ST-elevation myocardial infarction according to European and American guidelines.Aspiration Thrombectomy for Treatment of ST-segment Elevation Myocardial Infarction: a Meta-analysis of 26 Randomized Trials in 11,943 Patients.Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary.Coronary Stents: The Impact of Technological Advances on Clinical Outcomes.Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review.Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis.Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials.Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials.Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis.Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention.Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With DrSafety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis.Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality.Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials.Are the culprit lesions severely stenotic?Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study.New approach to direct stenting using a novel "all-in-one" coronary stent system via 5 French diagnostic catheters: a pilot study.Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials.Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials.Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry.Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents.Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland.A new device for vascular embolization: report on case of two pulmonary arteriovenous fistulas embolization using the amplatzer vascular plug.The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
P50
Q27004632-E4348C73-4F61-479F-9A48-868B5B8F26C2Q28542739-B8573DA4-AFF1-49F8-93A4-42971F39C350Q30492777-B74D27CC-CC28-4EE2-A90F-6A0CB0B2D4F6Q33791885-FC476341-799F-4185-9A07-EDF64535A4B2Q34450100-13BF2792-6960-47CC-9728-2133469BDB23Q34543682-006D7CD4-AB66-4FDC-A8F0-1AEC634E6D96Q35762839-E6BDD8D3-216F-474E-A549-5AE8FF72483EQ36835976-D22F9EF7-D448-40F4-B76D-6386B0E9C2C6Q38074477-0752BA18-3D28-448C-B541-A89F8F1D3E39Q38254363-CCBDA44B-4B98-4057-B34F-88239E1B1D7CQ38483607-0E162EFF-A150-42DA-B465-316618F38003Q38526979-ABA65B69-5E3A-4F75-B8A8-1F2AD51ABF7AQ38565074-AEB9CDB0-6285-4DB2-AFBE-60C32D768949Q38704416-31C04347-F2F5-43C3-B4B4-797FEAE2FD8AQ38991517-E62682A7-4954-49C7-845D-3FFC5AE7A415Q39284041-6ABCD0F5-D64B-48C9-B021-0EEE828FB682Q39360380-ED891038-99DA-45B8-843F-ACA0C0EBAEE8Q39690578-0E34D859-D5AB-4ADC-AF6C-9870FFE316BAQ39765991-5A1C0888-AF97-4764-B91B-6DFF43A52036Q40112204-B3939615-D8CB-4240-BBD1-3F906982EF28Q40126785-1A2C1091-7315-408C-B700-FCF315C0426DQ40453794-98F527ED-1D4C-4CC2-A10F-28CFD8563594Q40736980-695BEED5-06FB-46F2-93BB-2F52295E9C6AQ40812182-C3042DBD-C4F2-456F-A814-3FDB75FF18A5Q41613122-2C7F986A-CD89-4F8E-BE64-4F738B592992Q41758069-C0862A85-DAB0-4EC9-852D-3D78526A377FQ43503855-256A3D1D-D509-4C22-896D-AC318F59F88FQ43825081-60E6E219-F1CB-4969-AC66-E033DEB2C38AQ43864405-989A323E-EFAB-4043-AAAE-0116BE7DAF88Q43900785-EFB747AD-6F80-4113-8865-98C6DE311413Q44746175-60293F86-C492-457B-A92C-1155F2CD8FBDQ46529943-71DCF96F-950C-440E-A33E-AB3658816A2CQ47297262-910E67DC-48E2-4B56-9D22-C1ED9BAA0E69Q47833796-0E36C612-926D-42F9-AAEF-1B84F55C8304Q47909360-A7352A85-8284-4388-A742-81CF0A6AB271Q47921102-987AEDA8-0E99-4C98-9D30-EE2C583A2083Q47991913-56E816C9-D716-4FB4-A070-7261FB06E7BFQ48213904-C5B37C6D-4456-41C3-A5D2-568B711196D3Q48526931-1068D36B-04AE-4D22-81C9-2838AD561B44Q48541219-A213A898-6426-40C0-BAA5-B4EDC82B6156
P50
description
Italiaans cardioloog
@nl
Italian cardiologist
@en
cairdeolaí Iodálach
@ga
cardiólogu italianu
@ast
italienischer Kardiologe
@de
name
Giulio G. Stefanini
@sl
Giulio Stefanini
@ca
Giulio Stefanini
@en
Giulio Stefanini
@es
Giulio Stefanini
@fr
Giulio Stefanini
@ga
Giulio Stefanini
@nl
Giulio Stefanini
@sq
type
label
Giulio G. Stefanini
@sl
Giulio Stefanini
@ca
Giulio Stefanini
@en
Giulio Stefanini
@es
Giulio Stefanini
@fr
Giulio Stefanini
@ga
Giulio Stefanini
@nl
Giulio Stefanini
@sq
altLabel
Giulio G. Stefanini
@en
prefLabel
Giulio G. Stefanini
@sl
Giulio Stefanini
@ca
Giulio Stefanini
@en
Giulio Stefanini
@es
Giulio Stefanini
@fr
Giulio Stefanini
@ga
Giulio Stefanini
@nl
Giulio Stefanini
@sq
P1053
K-7406-2016
P106
P1153
14050996500
P19
P21
P27
P31
P3829
P496
0000-0002-3558-6967